<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02631980</url>
  </required_header>
  <id_info>
    <org_study_id>15-079</org_study_id>
    <nct_id>NCT02631980</nct_id>
  </id_info>
  <brief_title>HepciFer Study: Hepcidin Overexpression After Hepatectomy : Does Iron Supplementation Make Sense ?</brief_title>
  <acronym>HepciFer</acronym>
  <official_title>Hepcidin Overexpression After Hepatectomy : Does Iron Supplementation Make Sense ?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Geneva</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Geneva</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hepcifer Trial is designed to assess the value of iv iron administration immediately after&#xD;
      liver surgery and consequences of inflammation on iron balance. Fifty patients will be&#xD;
      randomized in two treatment groups. Patients will be assigned to receive either iv iron or&#xD;
      placebo immediately after liver resection surgery. Biological inflammation parameters,&#xD;
      hemoglobin, serum iron and hepcidin levels will be assessed prior to surgery and at day 1, 3,&#xD;
      7, 15 and 30 after surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The iron homeostasis is now well known. Indeed, the discovery of hepcidin, a protein&#xD;
      synthesized by the liver, has provided a better understanding of iron metabolism and the&#xD;
      resulting anemia disruption of this homeostasis.&#xD;
&#xD;
      Although morbidity decreased hepatic surgery remains a major surgery as by surgical&#xD;
      difficulty by support intra- and postoperatively.&#xD;
&#xD;
      A preliminary study, the investigators found that patients had preoperative anemia&#xD;
      (oncological context) increased postoperatively, increasing the morbidity.&#xD;
&#xD;
      Few clinical studies on hepcidin and anemia were carried out, because of the difficulty of&#xD;
      metering (mass spectrometry) as well as its cost.&#xD;
&#xD;
      In this clinical trial, the investigators plan to assess the value of iv iron administration&#xD;
      versus iv placebo treatment immediately after liver surgery and consequences of inflammation&#xD;
      on iron balance. In addition, an evaluation of the well being of patients will be performed&#xD;
      postoperatively to measure the functional and psychological impact of anemia.&#xD;
&#xD;
      This is a monocentric, randomized, double blinded and placebo controlled trial. Iron iv&#xD;
      injection will be administered postoperatively. Hematology assessments, biological iron&#xD;
      deficiency, inflammation and coagulation will be realized pre and postoperatively. Hepcidin&#xD;
      is assayed by an ELISA method.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Actual">October 2016</completion_date>
  <primary_completion_date type="Actual">October 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hemoglobin level</measure>
    <time_frame>Postoperative Day 7</time_frame>
    <description>Blood sample at postoperative Day 7</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life Questionnaire at day 30</measure>
    <time_frame>Postoperative Day 30</time_frame>
    <description>Questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Anemia</condition>
  <condition>Postoperative Blood Loss</condition>
  <arm_group>
    <arm_group_label>IV iron</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Postoperative iv iron administration (Ferinject) upon arrival in after surgery recovery room</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IV placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Postoperative iv placebo administration upon arrival in after surgery recovery room</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>IV iron</intervention_name>
    <description>Intravenous iron 15 mg/kg (max 1000 mg) in 250 ml 0.9% saline</description>
    <arm_group_label>IV iron</arm_group_label>
    <other_name>Ferinject</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>IV placebo</intervention_name>
    <description>Intravenous 0.9% saline (250 ml)</description>
    <arm_group_label>IV placebo</arm_group_label>
    <other_name>Placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Scheduled liver surgery,&#xD;
&#xD;
          -  Liver resection &gt; 2 segments.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age below 18yrs,&#xD;
&#xD;
          -  Pregnancy,&#xD;
&#xD;
          -  Emergent surgery,&#xD;
&#xD;
          -  Sepsis,&#xD;
&#xD;
          -  Immunosuppressive therapy,&#xD;
&#xD;
          -  Renal insufficiency (GFR&lt;30ml/min/m2),&#xD;
&#xD;
          -  Hypersensitivity to iron,&#xD;
&#xD;
          -  Iron overload.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eduardo Schiffer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Geneva</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Geneva</name>
      <address>
        <city>Geneva</city>
        <zip>1211</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <study_first_submitted>December 2, 2015</study_first_submitted>
  <study_first_submitted_qc>December 11, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 16, 2015</study_first_posted>
  <last_update_submitted>May 4, 2017</last_update_submitted>
  <last_update_submitted_qc>May 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Geneva</investigator_affiliation>
    <investigator_full_name>Eduardo Schiffer</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>Hepcidin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postoperative Hemorrhage</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

